[Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
In tests conducted on mice and rats with transplantable tumours the antineoplastic activity of the racemic agent D, L-1,4-dibromo-1, 4-didesoxy-2, 3-butandiol is shown. With chronic administration of the drug in subtherapeutic and therapeutic doses a higher leucocytes count was in evidence in the blood of the animals with and without tumours.